Clinical Trial Update: SB17170 Phase 1 Clinical Trial in Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update notes that SB17170 is in a Phase 1 study for solid tumors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SB17170

Snippet

Sponsor: SPARK Biopharma | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING